会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Substituted benzylaminopiperidine compounds
    • 取代的苄基氨基哌啶化合物
    • US06506775B1
    • 2003-01-14
    • US09564398
    • 2000-05-01
    • Kunio SatakeYuji ShishidoHiroaki Wakabayashi
    • Kunio SatakeYuji ShishidoHiroaki Wakabayashi
    • C07D21156
    • C07D211/56
    • The invention provides a compound of formula (I): and its pharmaceutically acceptable salts, wherein R is halo C2-C8 alkenyl or halo C2-C8 alkynyl; R1 is hydrogen, halo or C1-C6 alkoxy; or R and R1, together with the two carbon atoms to which they are attached, form a C4-C6 cycloalkyl or a C4-C6 oxacycloalkyl ring wherein said ring may be optionally substituted by one or more substituents selected from the group consisting of halo, C1-C6 alkyl and halo C1-C6 alkyl; X is C1-C6 alkoxy, halo C1-C6 alkoxy, phenoxy or halo; and Ar is phenyl optionally substituted by halo. These compounds are useful in the treatment of a gastrointestinal disorder; a central nervous system (CNS) disorder; an inflammatory disease; emesis; urinary incontinence; pain; migraine; sunburn; diseases, disorders and adverse conditions caused by Heliobacter pylori; or angiogenesis especially CNS disorders in a mammalian subject, especially humans.
    • 本发明提供式(I)化合物及其药学上可接受的盐,其中R为卤代C 2 -C 8烯基或卤代C 2 -C 8炔基; R 1为氢,卤素或C 1 -C 6烷氧基;或R和R 1与 它们连接的两个碳原子形成C 4 -C 6环烷基或C 4 -C 6氧杂环烷基环,其中所述环可任选地被一个或多个选自卤素,C 1 -C 6烷基和卤代C 1 -C 6烷基的取代基取代, C6烷基; X是C1-C6烷氧基,卤代C1-C6烷氧基,苯氧基或卤代; 并且Ar是任选被卤素取代的苯基。这些化合物可用于治疗胃肠道疾病; 中枢神经系统(CNS)障碍; 炎性疾病; 呕吐 尿失禁 疼痛; 偏头痛 晒斑; 由幽门螺杆菌引起的疾病,病症和不良状况; 或血管发生,尤其是哺乳动物受试者尤其是人类的CNS疾病。
    • 8. 发明授权
    • Tetrazolyl-substituted quinuclidines as substance P antagonists
    • 作为物质P拮抗剂的四唑基取代的奎宁子
    • US5939434A
    • 1999-08-17
    • US924171
    • 1997-09-05
    • Kunio Satake
    • Kunio Satake
    • A61K31/435A61K31/439A61P1/00A61P1/04A61P1/08A61P9/00A61P13/00A61P13/02A61P15/00A61P17/02A61P25/00A61P25/04A61P25/06A61P29/00A61P31/04A61P37/08A61P43/00C07D453/02A61K31/44
    • C07D453/02
    • This invention provides a compound of the formula: ##STR1## and its pharmaceutically acceptable salts, wherein R.sup.1 is halo, C.sub.1 -C.sub.6 alkyl, halo C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy or halo C.sub.1 -C.sub.6 alkoxy; R.sup.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, halo C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkyl-S-, C.sub.1 -C.sub.6 alkyl-SO--, C.sub.1 -C.sub.6 alkyl-SO.sub.2 --, cyclopropyl, phenyl, --NH.sub.2, --NH(CH.sub.3), --NHC(.dbd.O)CH.sub.3, --N(CH.sub.3).sub.2, --N(C.sub.2 H.sub.5).sub.2 or --CH.sub.2 C(.dbd.O)CF.sub.3 ; Ar.sup.1 and Ar.sup.2 are independently phenyl, halophenyl or thienyl; X is NH, O or S; and Y is hydrogen, --COOR.sup.3 or --CONR.sup.4 R.sup.5, wherein R.sup.3, R.sup.4 and R.sup.5 are independently hydrogen or C.sub.1 -C.sub.6 alkyl. These compounds are useful as analgesics or anti-inflammatory agents, or in the treatment of allergic disorders, angiogenesis, CNS disorders, emesis, gastrointestinal disorders, sunburn, urinary incontinence, or diseases, disorders or adverse conditions caused by Helicobacter pylori, or the like, in a mammalian subject, especially human, especially as analgesics or anti-inflammatory agents in the periphery.
    • 本发明提供下式化合物及其药学上可接受的盐,其中R 1为卤素,C 1 -C 6烷基,卤代C 1 -C 6烷基,C 1 -C 6烷氧基或卤代C 1 -C 6烷氧基; R2是氢,C1-C6烷基,卤代C1-C6烷基,C1-C6烷基-S-,C1-C6烷基-SO-,C1-C6烷基-SO2-,环丙基,苯基,-NH2,-NH(CH3 ),-NHC(= O)CH 3,-N(CH 3)2,-N(C 2 H 5)2或-CH 2 C(= O)CF 3; Ar1和Ar2独立地是苯基,卤代苯基或噻吩基; X是NH,O或S; 并且Y是氢,-COOR 3或-CONR 4 R 5,其中R 3,R 4和R 5独立地是氢或C 1 -C 6烷基。 这些化合物可用作止痛剂或抗炎剂,或用于治疗过敏性疾病,血管生成,CNS紊乱,呕吐,胃肠道疾病,晒伤,尿失禁或由幽门螺杆菌引起的疾病,病症或不利条件等 ,在哺乳动物受试者,特别是人类,特别是在周边的止痛剂或抗炎剂。